BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 19520758)

  • 1. Screening panels for detection of monoclonal gammopathies.
    Katzmann JA; Kyle RA; Benson J; Larson DR; Snyder MR; Lust JA; Rajkumar SV; Dispenzieri A
    Clin Chem; 2009 Aug; 55(8):1517-22. PubMed ID: 19520758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
    Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
    Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
    Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
    Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
    Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
    [No Abstract]   [Full Text] [Related]  

  • 6. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study.
    Kaplan B; Golderman S; Aizenbud B; Esev K; Kukuy O; Leiba M; Livneh A; Ben-Zvi I
    Am J Hematol; 2014 Sep; 89(9):882-8. PubMed ID: 24866208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
    Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
    Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
    Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
    Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
    Ansari AA; Tipu HN; Ahmed D; Farhan M
    Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
    Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
    Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of serum M-protein in acetonitrile precipitates by MALDI-TOF mass spectrometry: A novel, low-cost methodology.
    Mehra N; Gopisetty G; Subramani J; Dhanasekar S; Rajamanickam A; Perumal Kalaiyarasi J; Karunakaran P; Kannan K; Rajaraman S; Rajkumar T
    Ann Clin Biochem; 2023 Sep; 60(5):339-348. PubMed ID: 37158306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening panels for monoclonal gammopathies: time to change.
    Katzmann JA
    Clin Biochem Rev; 2009 Aug; 30(3):105-11. PubMed ID: 19841692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The monoclonal gammopathies.
    Kyle RA
    Clin Chem; 1994 Nov; 40(11 Pt 2):2154-61. PubMed ID: 7955402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of amyloidogenic light chains requires the combination of serum-free light chain assay with immunofixation of serum and urine.
    Palladini G; Russo P; Bosoni T; Verga L; Sarais G; Lavatelli F; Nuvolone M; Obici L; Casarini S; Donadei S; Albertini R; Righetti G; Marini M; Graziani MS; Melzi D'Eril GV; Moratti R; Merlini G
    Clin Chem; 2009 Mar; 55(3):499-504. PubMed ID: 19131635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical usefulness of serum free light chain measurement in monoclonal gammopathy].
    Shimazaki C; Murakami H; Sawamura M; Matsuda M; Kinoshita T; Hata H; Sugiura I; Tsushita K; Nagura E; Kosugi H; Itoh J; Shimizu K
    Rinsho Ketsueki; 2010 Apr; 51(4):245-52. PubMed ID: 20467220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.